Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work

Last updated: February 11, 2025
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Overall Status: Active - Recruiting

Phase

N/A

Condition

Breast Cancer

Cancer

Treatment

Questionnaires

back to work coaching

Clinical Study ID

NCT05056350
PROICM 2020-07 VIS
2020-A00955-34
  • Ages > 18
  • Female

Study Summary

The diagnosis of breast cancer and the treatments implemented have a significant impact on the professional situation.

Maintaining employment and/or reintegration into working life are therefore major issues for cancer patients.

This trial proposes to study the feasibility of a support/coaching program for a return to work in patients after breast cancer.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age ≥18 years

  • Patients cared at the Montpellier Cancer Institute (ICM) for non-metastatic breastcancer who have received adjuvant treatment (radiotherapy and/or chemotherapy)

  • Patient who has completed adjuvant treatment, except for hormonotherapy

  • Patient practicing a profession at the time of diagnosis, looking for a job or inprofessional retraining at the time of diagnosis

  • Patient expressing spontaneously or on request of the oncologist physical orpsychological difficulties in the professional field

  • Patient wishing to be accompanied for an adapted return to her current job or for areturn to a new more adapted job

  • Patient who signed the informed consent after informed information by her clinician

Exclusion

Exclusion Criteria:

  • Metastatic breast cancer or any other cancer within the last 5 years

  • Patient who haven't completed herr adjuvant treatment (chemotherapy and/orradiotherapy)

  • Psychological condition requiring therapeutic support (objectified by the MiniInternational Neuropsychiatric Interview test (MINI) by identifying a Diagnostic andStatistical Manual (DSM)-IV Axis I psychiatric disorder (American PsychiatricAssociation, 1994) Sheehan et al., 1998) with the patient's refusal of adequatepsychiatric treatment (medicated or not) at the time of inclusion in the study

  • Severely impaired global cognitive functioning (objectified by an adjusted score ofless than 20 on the Montreal Cognitive Assessment (MoCA) test)

  • Physical inability to answer questionnaires

Study Design

Total Participants: 25
Treatment Group(s): 2
Primary Treatment: Questionnaires
Phase:
Study Start date:
September 13, 2021
Estimated Completion Date:
August 22, 2027

Study Description

This study involves patients with breast cancer at the end of their adjuvant treatment.

The aim of this study is to evaluate the feasibility of a support program for an adapted return to work of these patients.

This back-to-work support program including an individual interview to identify patient needs and expectations, 7 coaching workshops (every 3 weeks +/- 15 days) and a final individual assessment post workshops.

The evolution of quality of life, psychological distress and perceptions concerning work will also be evaluated through assessments and questionnaires before (inclusion) and after the support program [1 month (+/- 7 days) and 6 months (+/- 1 month) after the final individual assessment].

The study also aims to estimate the recruitment rate in the study and to assess the satisfaction of this support program.

Finally, the impact of this support program on the return to work will be described.

This initial study will eventually lead to a larger research protocol on the effectiveness of the program, using a randomized controlled trial design.

Connect with a study center

  • Institut du Cancer de Montpellier

    Montpellier, 34298
    France

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.